Supriya Lifescience Ltd
NSE:SUPRIYA
Supriya Lifescience Ltd
NSE:SUPRIYA
Price:
747.35
INR
0.46%
Market Cap:
60.1B
INR
Balance Sheet
Balance Sheet Decomposition
Supriya Lifescience Ltd
Supriya Lifescience Ltd
| Current Assets | 4.1B |
| Cash & Short-Term Investments | 869.6m |
| Receivables | 1.1B |
| Other Current Assets | 2.2B |
| Non-Current Assets | 6B |
| Long-Term Investments | 724.9m |
| PP&E | 5.2B |
| Intangibles | 27m |
| Other Non-Current Assets | 11.7m |
Balance Sheet
Supriya Lifescience Ltd
Supriya Lifescience Ltd
Currency: INR
Millions
Annual
| Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
27
|
17
|
15
|
435
|
1 658
|
774
|
400
|
|
| Cash |
27
|
17
|
15
|
9
|
232
|
78
|
118
|
|
| Cash Equivalents |
0
|
0
|
0
|
426
|
1 426
|
695
|
281
|
|
| Short-Term Investments |
59
|
107
|
732
|
488
|
682
|
866
|
395
|
|
| Total Receivables |
563
|
770
|
569
|
826
|
1 327
|
1 523
|
2 015
|
|
| Accounts Receivables |
534
|
600
|
525
|
735
|
1 152
|
847
|
1 117
|
|
| Other Receivables |
29
|
170
|
44
|
91
|
176
|
676
|
898
|
|
| Inventory |
317
|
307
|
495
|
725
|
923
|
1 158
|
852
|
|
| Other Current Assets |
230
|
128
|
170
|
181
|
386
|
329
|
316
|
|
| Total Current Assets |
1 196
|
1 329
|
1 980
|
2 655
|
4 975
|
4 649
|
3 978
|
|
| PP&E Net |
1 249
|
1 180
|
1 350
|
1 772
|
2 317
|
3 281
|
4 573
|
|
| PP&E Gross |
1 249
|
1 180
|
1 350
|
1 772
|
2 317
|
3 281
|
4 573
|
|
| Accumulated Depreciation |
46
|
94
|
154
|
220
|
319
|
433
|
587
|
|
| Intangible Assets |
5
|
20
|
32
|
16
|
15
|
11
|
17
|
|
| Note Receivable |
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
1
|
1
|
1
|
1
|
1
|
253
|
638
|
|
| Other Long-Term Assets |
1
|
0
|
2
|
11
|
40
|
9
|
7
|
|
| Total Assets |
2 454
N/A
|
2 531
+3%
|
3 364
+33%
|
4 455
+32%
|
7 348
+65%
|
8 203
+12%
|
9 212
+12%
|
|
| Liabilities | ||||||||
| Accounts Payable |
418
|
441
|
494
|
510
|
490
|
642
|
596
|
|
| Accrued Liabilities |
9
|
12
|
15
|
9
|
4
|
8
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
674
|
213
|
166
|
0
|
|
| Current Portion of Long-Term Debt |
950
|
817
|
798
|
27
|
8
|
4
|
5
|
|
| Other Current Liabilities |
82
|
78
|
247
|
240
|
282
|
137
|
165
|
|
| Total Current Liabilities |
1 459
|
1 349
|
1 554
|
1 460
|
997
|
958
|
769
|
|
| Long-Term Debt |
353
|
107
|
47
|
21
|
53
|
55
|
50
|
|
| Deferred Income Tax |
90
|
97
|
75
|
80
|
111
|
137
|
232
|
|
| Other Liabilities |
6
|
40
|
196
|
208
|
29
|
59
|
8
|
|
| Total Liabilities |
1 907
N/A
|
1 593
-17%
|
1 872
+18%
|
1 769
-6%
|
1 191
-33%
|
1 208
+1%
|
1 059
-12%
|
|
| Equity | ||||||||
| Common Stock |
146
|
146
|
146
|
146
|
161
|
161
|
161
|
|
| Retained Earnings |
400
|
792
|
1 346
|
2 539
|
5 996
|
6 834
|
7 993
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
547
N/A
|
938
+72%
|
1 492
+59%
|
2 686
+80%
|
6 157
+129%
|
6 995
+14%
|
8 154
+17%
|
|
| Total Liabilities & Equity |
2 454
N/A
|
2 531
+3%
|
3 364
+33%
|
4 455
+32%
|
7 348
+65%
|
8 203
+12%
|
9 212
+12%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
80
|
80
|
80
|
73
|
80
|
80
|
80
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
